<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04225507</url>
  </required_header>
  <id_info>
    <org_study_id>IRB19-1445</org_study_id>
    <secondary_id>R01DK120312</secondary_id>
    <nct_id>NCT04225507</nct_id>
  </id_info>
  <brief_title>Technology-Supported Treatment of Sleep Apnea in Prediabetes</brief_title>
  <acronym>TECH</acronym>
  <official_title>Technology-Supported Treatment of Sleep Apnea in Prediabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Chicago</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite the efficacy of intensive lifestyle interventions in prediabetes, the incidence of
      diabetes is rising, and thus there is a critical need for additional strategies to prevent
      diabetes and to reduce its cardiovascular complications in this high-risk population. Sleep
      apnea is a highly common condition in prediabetes, but it has been mostly ignored and
      undertreated in current practice. The proposed study will be the first to assess whether
      adding CPAP (continuous positive air pressure) treatment to a lifestyle intervention improves
      cardiometabolic outcomes beyond that achieved with lifestyle alone (i.e. current standard of
      care) in high-risk individuals with prediabetes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a 6-month randomized controlled, parallel group trial with two arms. After baseline,
      the subjects will be randomized to lifestyle intervention alone (lifestyle group) or
      lifestyle plus CPAP intervention (lifestyle plus CPAP group). The same metabolic and
      cardiovascular assessments will be performed at baseline and after 6-months of intervention.

      The lifestyle group will aim to achieve a weight loss through diet and exercise. The
      lifestyle plus CPAP group will additionally receive CPAP treatment. All subjects will use a
      custom smartphone app to track weight loss and/or CPAP goals and will receive weekly coaching
      phone calls to maximize treatment adherence.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2020</start_date>
  <completion_date type="Anticipated">July 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline 2-hour glucose levels at 6 months</measure>
    <time_frame>Baseline and at 6 months</time_frame>
    <description>Glucose levels will be measured at time=120min during oral glucose tolerance test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline morning blood pressure at 6 months</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Morning blood pressure will be measured with a blood pressure cuff while sitting</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline fasting glucose levels at 6 months</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>Fasting blood glucose levels will be measured in the morning</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline 24-hour blood pressure at 6 months</measure>
    <time_frame>Baseline and 6 months</time_frame>
    <description>24-hour blood pressure will be measured using and ambulatory blood pressure device</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">740</enrollment>
  <condition>Sleep Apnea</condition>
  <condition>PreDiabetes</condition>
  <condition>Overweight or Obesity</condition>
  <arm_group>
    <arm_group_label>Lifestyle Intervention</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Diet and exercise.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lifestyle Plus CPAP Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CPAP treatment, diet and exercise.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Diet and exercise coaching</intervention_name>
    <description>All participants will receive diet and exercise goals and coaching.</description>
    <arm_group_label>Lifestyle Intervention</arm_group_label>
    <arm_group_label>Lifestyle Plus CPAP Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CPAP Treatment</intervention_name>
    <description>CPAP treatment for sleep apnea and CPAP education and adherence coaching.</description>
    <arm_group_label>Lifestyle Plus CPAP Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Overweight or obese

          -  Prediabetes

          -  Sleep apnea

        Exclusion Criteria:

          -  Diabetic

          -  enrolled in a formal weight loss program

          -  Any underlying disease likely to limit life span and/or increase risk of interventions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Esra Tasali, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Millie Maleckar</last_name>
      <phone>773-702-6505</phone>
      <email>mmalecka@bsd.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>Esra Tasali, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>January 7, 2020</study_first_submitted>
  <study_first_submitted_qc>January 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 13, 2020</study_first_posted>
  <last_update_submitted>April 22, 2020</last_update_submitted>
  <last_update_submitted_qc>April 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

